KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $25.9 billion.

  • Elevance Health's Short-term Investments rose 271.02% to $25.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $25.9 billion, marking a year-over-year increase of 271.02%. This contributed to the annual value of $25.9 billion for FY2025, which is 271.02% up from last year.
  • Per Elevance Health's latest filing, its Short-term Investments stood at $25.9 billion for Q4 2025, which was up 271.02% from $26.3 billion recorded in Q3 2025.
  • In the past 5 years, Elevance Health's Short-term Investments registered a high of $29.6 billion during Q4 2023, and its lowest value of $24.6 billion during Q1 2021.
  • For the 5-year period, Elevance Health's Short-term Investments averaged around $26.8 billion, with its median value being $26.2 billion (2021).
  • Its Short-term Investments has fluctuated over the past 5 years, first soared by 2350.99% in 2021, then crashed by 1490.17% in 2024.
  • Elevance Health's Short-term Investments (Quarter) stood at $26.3 billion in 2021, then dropped by 1.2% to $26.0 billion in 2022, then grew by 14.11% to $29.6 billion in 2023, then dropped by 14.9% to $25.2 billion in 2024, then grew by 2.71% to $25.9 billion in 2025.
  • Its last three reported values are $25.9 billion in Q4 2025, $26.3 billion for Q3 2025, and $25.3 billion during Q2 2025.